SCHEMBL385743

SCHEMBL385743

C[C]OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2796481 0.70
SCHEMBL4096257 0.70
SCHEMBL2874785 0.69
SCHEMBL8728381 0.69
SCHEMBL14721076 0.69
SCHEMBL4072490 0.64
SCHEMBL3521050 0.64
SCHEMBL2897 0.64
SCHEMBL2054 0.64
SCHEMBL387765 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 410 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112638864-A Traceless reductively cleavable linker molecules for peptide purification 贝兰迪克有限责任公司 2021-04-09 CN claimed
CN-106543314-B The application of catalyst containing ether ester and the catalyst and ether ester in olefin polymerization 中国石油化工股份有限公司 2019-02-19 CN claimed
US-6998479-B1 Derivatives of cyclodextrins KHOMUTOV ALEXEI 2006-02-14 US claimed
EP-1090041-A1 NOVEL DERIVATIVES OF CYCLODEXTRINS Khomutov, Alexei Radievich (RU) 2001-04-11 EP claimed
WO-1999045032-A1 NOVEL DERIVATIVES OF CYCLODEXTRINS KHOMUTOV ALEXEI RADIEVICH (RU) 1999-09-10 WO claimed
WO-2024135721-A1 METHOD FOR PRODUCING PRODUCTION INTERMEDIATE, PRODUCTION INTERMEDIATE THEREOF, AND METHOD FOR PRODUCING CROSSLINKED ARTIFICIAL NUCLEIC ACID INTERMEDIATE BY USING SAME 田辺三菱製薬株式会社 2024-06-27 WO disclosed
EP-4381070-A2 CHEMICALLY MODIFIED OLIGONUCLEOTIDES Phio Pharmaceuticals Corp. (US) 2024-06-12 EP disclosed
US-20240116981-A1 TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION Belyntic GmbH (DE) 2024-04-11 US disclosed
WO-2024064769-A1 INDUCTION OF STEM-LIKE ACTIVATED T CELLS PHIO PHARMACEUTICALS CORP. (US) 2024-03-28 WO disclosed
CN-112638864-B Traceless reductive cleavable linker molecules for peptide purification 格瑞罗斯普罗泰恩科技公司 2024-03-08 CN disclosed
EP-3160475-B1 SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES TO TREAT FILOVIRIDAE INFECTIONS JANSSEN PHARMACEUTICALS INC (US) 2024-01-03 EP disclosed
EP-4288110-A2 TECHNOLOGIES FOR PREVENTING OR TREATING INFECTIONS Biohaven Therapeutics Ltd. (US) 2023-12-13 EP disclosed
EP-0155625-A2 Glycolipid-like substances in liposome form BAYER AG (DE) 1985-09-25 EP disclosed
EP-0149760-A2 Substituted O-acyl glycosylamides, methods for their preparation and their use BAYER AG (DE) 1985-07-31 EP disclosed
EP-0143385-A2 Phosphorylised glycosil amides, ureas, carbamates and thiocarbamates, method for their preparation and their use BAYER AG (DE) 1985-06-05 EP disclosed
US-4340728-A ANTITUMOR AGENT OF 5-FLUORO URIDINE OR URACIL DERIVATIVE FUJI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1982-07-20 US disclosed
US-4322419-A Bicyclomycin derivatives, compositions thereof and process of use thereof CIBA-GEIGY CORPORATION (US) 1982-03-30 US disclosed
US-4251517-A FUNGICIDES CIBA-GEIGY CORPORATION (US) 1981-02-17 US disclosed
US-4145344-A BICYCLOMYCIN DERIVATIVES CIBA-GEIGY CORPORATION (US) 1979-03-20 US disclosed
US-4035512-A Aminotetralols TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1977-07-12 US disclosed